HealthDay News — Cocoa extract supplementation yields a significant reduction in high-sensitivity C-reactive protein (hsCRP) and an increase in interferon-γ (IFN-γ), while no significant effects are ...

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu as a second-line therapy for HER2-positive metastatic breast ...

Cesium-137 is a man-made radioactive element sometimes found in contaminated soil, water or food, and has been linked to cancer.

Visual outcomes were similar to or slightly better for teenagers aged 17 and 18 years than adults aged 19 to 40 years.

HealthDay News — Costco has recalled more than 3000 pounds of its Kirkland Signature Ahi Tuna Wasabi Poke after testing found a risk of listeria contamination.

A phase 1/2 study is currently underway to evaluate SAR446268 in participants aged 10 to 50 years with non-congenital myotonic dystrophy type 1.

After 36 months, patients treated with high dose AMT-130 saw a 75% slowing of disease progression vs the external control.

The COMPASS PWS trial was a 12-week, randomized, double-blind, placebo-controlled, parallel-group study that included 175 patients aged 5 to 30 years with PWS.

HealthDay News — In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes, ...

Zilganersen is an antisense oligonucleotide designed to block the production of excess GFAP caused by mutations in the GFAP gene.

The EXCALIBER-RRMM study evaluated the efficacy and safety of iberdomide, an investigational cereblon E3 ligase modulator, in combination with dexamethasone and daratumumab in adults with RRMM.

Apitegromab, a fully human monoclonal antibody, works by selectively binding to the pro- and latent forms of myostatin in order to inhibit myostatin activation.